Home - Melanoma Research Alliance

From Health Scare to Transformative Change

When Debra Black was diagnosed with Stage II acral melanoma, she was shocked to learn that the treatment landscape hadn’t changed in almost 40 years. So, later that year she and her husband Leon founded the Melanoma Research Alliance.

Since then, MRA has directly invested more than $101 million in cutting-edge melanoma research world-wide and has leveraged an additional $101 million from other sources.
Read Debra's Story
It’s Not that Simple: Young Women and Melanoma

Article after article describes the ‘skyrocketing’ increases in melanoma among young women. While most are quick to point out the clear association between intentional tanning and skin cancer, few ever hint that there may be more to the story.
Read More
Unchartered Territory: When Should Patients Stop Immunotherapy?

For melanoma patients, deciding when to discontinue treatment is a difficult decision. should the general ‘rule of thumb’ of treating patients with advanced disease until progression still apply? In the absence of definitive data – what does indirect data tell us?
Read More
Doing Good in Rebecca's Name

It was March of 2005 when Christine Garrison’s life changed forever. She received the phone call that no mother ever wants to receive. Her daughter Rebecca’s suspicious mole was, in fact, Stage 3 melanoma.
Read Christine's Story
Melanoma Treatment Advances – 2018 in Review

2018 brought new and expanded drug approvals that give patients, doctors, and their families more treatment options with fewer side effects. Learn more about important melanoma treatment advances in 2018.
Learn More

Find a Clinical Trial
Get Connected

Scientific Report
Get Involved
About MRA

What's New

12/18/2018 – MRA/ACS Joint Funding Opportunity: Understanding and Managing Metastasis

12/03/2018 – MRA Advisor & Grantee Dr. Allison Awarded Nobel Prize for Transforming Cancer Care

11/01/2018 – Connecting the Dots: MRA’s 2017-2018 Annual Report

10/04/2018 – Melanoma Research Alliance Appoints Marc Hurlbert, Ph.D. Chief Science Officer

10/01/2018 – Melanoma Research Alliance Applauds Jim Allison for Nobel Prize in Medicine

MRA would like to thank our 2018 Retreat Sponsors